Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transporters

被引:9
作者
Roman, DL
Saldaña, SN
Nichols, DE
Carroll, FI
Barker, EL
机构
[1] Purdue Univ, Dept Med Chem & Mol Pharmacol, Sch Pharm & Pharmacal Sci, W Lafayette, IN 47907 USA
[2] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1124/jpet.103.057836
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, human embryonic kidney (HEK)-293 cells stably expressing human, Drosophila, or a chimeric serotonin (5-hydroxytryptamine, 5-HT) transporter (hSERT, dSERT, and H1-281D282-476H477-638, respectively) were used to explore the ability of two libraries of structurally distinct psychostimulants to inhibit 5-HT uptake. One library consisted of 3-phenyltropane analogs, whereas the second library consisted of several substituted amphetamines. hSERT exhibited a lower K-i value for all the compounds in both libraries compared with dSERT, whereas the chimeric SERT exhibited properties more closely resembling those of dSERT. This species selectivity was explored using computer-generated comparative molecular field analysis to model the interactions of the cocaine analogs and amphetamines at hSERT, dSERT, and the cross-species chimera. Models for the 3-phenyltropane analogs indicate that a region exists around the aromatic ring where decreased electron density is favored, particularly for hSERT. This finding may indicate pi-pi stacking with an aromatic amino acid residue in SERT. Also, electronegative substituents in the 4'-position provide favorable interactions. This structural feature was demonstrated by increased potency of analogs with electronegative substituents on the aromatic ring that withdraw electron density. For the substituted amphetamines, key areas for interaction exist around the amine, an electrostatic component surrounding the 3-position on the aromatic ring, and a steric component surrounding the 4-position.
引用
收藏
页码:679 / 687
页数:9
相关论文
共 41 条
[1]   Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition [J].
Adkins, EM ;
Barker, EL ;
Blakely, RD .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :514-523
[2]   NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[3]   Neurotransmitter transporters as molecular targets for addictive drugs [J].
Amara, SG ;
Sonders, MS .
DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) :87-96
[4]  
Barker EL, 1999, J NEUROSCI, V19, P4705
[5]   High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis - An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol [J].
Barker, EL ;
Perlman, MA ;
Adkins, EM ;
Houlihan, WJ ;
Pristupa, ZB ;
Niznik, HB ;
Blakely, RD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) :19459-19468
[6]  
Barker Eric L., 1995, P321
[7]  
BLAKELY RD, 1994, J EXP BIOL, V196, P263
[8]   Synthesis and transporter binding properties of 3ß-[4′(phenylalkyl, -phenylalkenyl, and -phenylalkynl)phenyl]tropane-2ß-carboxylic acid methyl esters:: Evidence of a remote phenyl binding domain on the dopamine transporter [J].
Blough, BE ;
Keverline, KI ;
Nie, Z ;
Navarro, H ;
Kuhar, MJ ;
Carroll, FI .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :4029-4037
[9]   Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: Serotonin transporter selective analogs [J].
Blough, BE ;
Abraham, P ;
Lewin, AH ;
Kuhar, MJ ;
Boja, JW ;
Carroll, FI .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) :4027-4035
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3